2007

130.)   Chunling Wa, Rangan Mallik and David S. Hage*. “Development of Sulfhydryl-Reactive Silica for Protein Immobilization in High-Performance Affinity Chromatography” Analytical Chemistry  79(4) (2007) 1411-1424.   

2006

116.)     John E. Schiel and David S. Hage*, “Density Measurements of Potassium Phosphate Buffer from 4 to 45EC”, Talanta, 65 (2005) 495-500.

117.)     David S. Hage*, “Affinity Chromatography”, Encyclopedia of Analytical Science, 2^nd Ed., P. Worsfold, A. Townshend, C. Poole (eds.), Elsevier, 2005, pp. 190-197 (vol. 5). (invited review)  

118.)     Chunling Wa, Ron L. Cerny and David S. Hage*.  “Identification and Quantitative Studies of Protein Immobilization Sites by Stable Isotope Labeling and Mass Spectrometry”,  Analytical Chemistry  78(23) (2006) 7967-7977.

119.)     Corey M. Ohnmacht, John E. Schiel and David S. Hage*.  “Analysis of Free Drug Fractions Using Near-Infrared Fluorescent Labels and an Ultrafast Immunoextraction/Displacement Assay”,  Analytical Chemistry  78(21) (2006) 7547-7556.  

120.)    Rangan Mallik and David S. Hage*.  ”Affinity monolith chromatography”,  Journal of Separation Science  29(12) (2006) 1686-1704.

121.)    Hai Xuan and David S. Hage*.  “Evaluation of a hydrazide-linked a 1-acid glycoprotein chiral stationary phase: separation of R- and S-propranolol”,  Journal of Separation Science  29(10) (2006) 1412-1422.  

122.)    David S. Hage*.  “Analysis of environmental contaminants by rapid chromatographic immunoassays and on-line immunoextraction”,  Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10-14, 2006  (2006)  AGRO-219.

123.)   Annette C. Moser, Charles Kingsbury and David S. Hage*.  “Stability of warfarin solutions for drug-protein binding measurements: Spectroscopic and chromatographic studies”,  Journal of Pharmaceutical and Biomedical Analysis  41(4) (2006) 1101-1109.  

124.)    Hee Seung Kim , Rangan Mallik and David S. Hage*.  “Chromatographic analysis of carbamazepine binding to human serum albumin”,  Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences  837(1-2) (2006) 138-146.

125.)    Corey M. Ohnmacht, Shirley Chen , Zenghan Tong and David S. Hage*.  “Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin”,  Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences  836(1-2) (2006) 83-91.  

126.)    John E. Schiel, Rangan Mallik, Sony Soman, Krina S. Joseph, and David S. Hage*. ”Applications of silica supports in affinity chromatography”,  Journal of Separation Science  29(6) (2006) 719-737.

127.)    Jianzhong Chen and David S. Hage*. “Quantitative Studies of Allosteric Effects by Biointeraction Chromatography: Analysis of Protein Binding for Low-Solubility Drugs”,  Analytical Chemistry  78(8) (2006) 2672-2683.

128.)    Chunling Wa, Ron Cerny and David S. Hage*.  “Obtaining high sequence coverage in matrix-assisted laser desorption time-of-flight mass spectrometry for studies of protein modification: Analysis of human serum albumin as a model”,  Analytical Biochemistry  349(2) (2006) 229-241.

129.)    Jianzhong Chen, Ilona Fitos and David S. Hage*. “Chromatographic analysis of allosteric effects between ibuprofen and benzodiazepines on human serum albumin”, Chirality  18(1) (2006) 24-36.

2005

101.)     John E. Schiel and David S. Hage*, “Density Measurements of Potassium Phosphate Buffer from 4 to 45EC”, Talanta, 65 (2005) 495-500.

102.)    David S. Hage*, “Affinity Chromatography”, Encyclopedia of Analytical Science, 2^nd Ed., P. Worsfold, A. Townshend, C. Poole (eds.), Elsevier, 2005, pp. 190-197 (vol. 5). (invited review)

103.)    David S. Hage*, “Affinity Chromatography”, Kirk-Othmer Encyclopedia of Chemical Technology,Online Edition, Azra Seidel (ed.), Wiley, in press (invited review).

104.)     David S. Hage (Editor), Handbook of Affinity Chromatography, CRC Press/Taylor & Francis, 2005.

105.)     David S. Hage*, "Affinity Chromatography: An Overview", In: Encyclopedia of Chromatography, 2^nd ed., J. Cazes (Editor), Marcel Dekker, New York , 2005, pp. 33-39.        

106.)     David S. Hage*, "Immunoaffinity Chromatography", In: Encyclopedia of Chromatography, 2^nd ed., J. Cazes (Editor), Marcel Dekker, New York , 2005, pp. 822-827.

107.)     David S. Hage*, "Binding Constants: Determination by Affinity Chromatography", In: Encyclopedia of Chromatography, 2^nd ed., J. Cazes (Editor), Marcel Dekker, New York , 2005, 184-190.

108.)     Heeseung Kim and David S. Hage*, “Chromatographic Analysis of Carbamazepine Binding to Human Serum Albumin”, J. Chromatogr. B, 816 (2005) 57-66.                                              

109.)     Annette Moser, Mary Anne Nelson and David S. Hage*, “Environmental Applications of Immunoaffinity Chromatography”, in: Immunoassay and Other Bioanalytical Techniques, J. Van Emon (Ed.), Marcel Dekker: New York , in press.

110.)     Tao Jiang, Rangan Mallik and David S. Hage*, “Affinity Monoliths for Ultrafast Immunoextraction”, Anal. Chem., 77 (2005) 2362-2372.

111.)     William Clarke, John E. Schiel, Annette Moser and David S. Hage*, “Analysis of Free Hormone Fractions by an Ultrafast Immunoextraction/Displacement Immunoassay: Studies Using Free Thyroxine as a Model System”, Anal.  Chem., 77 (2005) 1859-1866.

112.)     David S. Hage* and Rangan Mallik, “Affinity Monoliths for Ultrafast Immunoextraction & Chiral Separations”, LabPlus Intl., 19 (2005) 6-9.  

113.)    Jianzhong Chen, Ilona Fitos and David S. Hage*, “Chromatographic Analysis of Allosteric Effects Between Ibuprofen and Benzodiazepines on Human Serum Albumin”, Chirality, in press.

114.)    Hai Xuan and David S. Hage*, “Immobilization of "₁-Acid Glycoprotein for Chromatographic Studies of Drug-Protein Binding”, Anal. Biochem., 346 (2005) 300-310.

115.)     David S. Hage*, “Chromatography & Electrophoresis” In: Contemporary Practice in Clinical Chemistry, W.A. Clarke and D.R. Dufour (Eds.), AACC Press: Washington , DC , in press.

92.)     David S. Hage*, “Weak Affinity Chromatography”, Dekker Encyclopedia of Chromatography, J. Cazes (ed.), Marcel Dekker, 2004, online article (invited review).

93.)      Hee Seung Kim, John Austin and David S. Hage*, “Screening Major Binding Sites on Human Serum Albumin by Affinity Capillary Electrophoresis”, Capillary Electrophoresis of Proteins and Peptides, M. A. Strege and A. L. Lagu (eds.), Humana Press, 2004, Chap. 9. (invited research article).

94.)      Jianzhong Chen, Corey M. Ohnmacht and David S. Hage*, “Characterization of Drug Interactions with Soluble $-Cyclodextrin by High-Performance Affinity Chromatography”, J. Chromatogr. A, 1033 (2004) 115-126.

95.)      Mary Anne Nelson, Arther Gates, Maud Dodlinger and David S. Hage*, “Development of a Portable Immunoextraction/RPLC System for Field Studies of Herbicide Residues”, Anal. Chem., 76 (2004) 805-813.

96.)      Hee Seung Kim, Young Sik Kye and David S. Hage*, “Development & Evaluation of N-Hydroxysuccinimide-Activated Silica for Immobilization of Human Serum Albumin in HPLC Columns”, J. Chromatogr. A, 1049 (2004) 51-61.

97.)      Jianzhong Chen, Corey Ohnmacht and David S. Hage*, “Studies of Phenytoin Binding to Human Serum Albumin by High-Performance Affinity Chromatography”, J. Chromatogr. B, 809 (2004) 137-145.

98.)      Jianzhong Chen and David S. Hage*, “Quantitative Analysis of Allosteric Drug-Protein Binding by Biointeraction Chromatography”, Nature Biotechnol., 22 (2004) 1445-1448.

99.)      David S. Hage* and Arundhati Sengupta, "Correction: Studies of Protein Binding to Non-Polar Solutes by using Zonal Elution and High-Performance Affinity Chromatography: Interactions of cis- and trans-Clomiphene with Human Serum Albumin in the Presence of $-Cyclodextrin", Anal. Chem., 76 (2004) 5982.

100.)     Rangan Mallik, Tao Jiang and David S. Hage*, “High-Performance Affinity Monolith Chromatography: Development & Evaluation of Human Serum Albumin Columns”, Anal. Chem., 76 (2004) 7013-7022.

86.)      Mary Anne Nelson, Wanda S. Reiter and David S. Hage*, “Chromatographic Competitive Binding Immunoassays: A Comparison of the Sequential and Simultaneous Injection Methods”, Biomed. Chromatogr., 17 (2003) 188-200.

87.)      David S. Hage, “Clinical Applications of Affinity Chromatography”, Advances in Chromatography,  vol. 42, P. R. Brown and H. Isaaq, Editors, Marcel Dekker, Chap. 8, 2003.

88.)      William Clarke and David S. Hage*, “Clinical Applications of Affinity Chromatography”, Separation Techniques in Clinical Chemistry, H. Y. Aboul-Enein, Editor, Marcel Dekker, 2003 (Invited book chapter).

89.)      David S. Hage* and William Clarke, “Immunoaffinity Chromatography in Clinical Analysis”,  Separation Techniques in Clinical Chemistry, H. Y. Aboul-Enein, Editor, Marcel Dekker, 2003 (Invited book chapter).

90.)      William Clarke and David S. Hage*, “Clinical Applications of Affinity Chromatography”, Separation and Purification Reviews, 32 (2003) 19-60 (invited review).

91.)      David S. Hage*, “Using Periodate with Nitrite Solutions for Capillary Electrophoresis”, J. Chem. Educ. 80 (2003) 1138.

83.)      David S. Hage*, "High-Performance Affinity Chromatography: A Powerful Tool for Studying Serum Protein Binding", J. Chromatogr. B, 768 (2002) 3-30 (Invited review).

84.)      Hee Seung Kim, John Austin and David S. Hage*, “Identification of Drug-Binding Sites on Human Serum Albumin using Affinity Capillary Electrophoresis and Chemically Modified Proteins as Buffer Additives”, Electrophoresis, 23 (2002) 956-963.

85.)      Matthew R. Oates, William Clarke, Alden Zimlich II and David S. Hage*, “Optimization and Development of an HPLC-Based One-Site Immunometric Assay with Chemiluminescence Detection”, submitted to Anal. Chim. Acta, 470 (2002) 37-50.

76.)      David S. Hage*, "Chromatographic and Electrophoretic Studies of Protein Binding to Chiral Solutes", J. Chromatogr. B, 906 (2001) 459.

77.)      David S. Hage* and Mary Anne Nelson, "Chromatographic Immunoassays", Anal. Chem., 73 (2001) 198A-205A (Invited A-Page review)

78.)      William Clarke and David S. Hage*, "Development of Sandwich HPLC Microcolumns for Millisecond Extractions of Analytes", Anal. Chem., 73 (2001) 1366-1373.

79.)      William Clarke, A. Roy Choudhuri and David S. Hage*, "Analysis of Free Drug Fractions by Ultra-fast Immunoaffinity Chromatography", Anal. Chem., 73 (2001) 2157-2164.

80.)      David S. Hage* and William Clarke, "Affinity Chromatography: An Overview", In: Encyclopedia of Chromatography, J. Cazes (Editor), Marcel Dekker, New York , 2001, Chap. 8.  

81.)     David S. Hage* and John Austin, "Immunoaffinity Chromatography", In: Encyclopedia of Chromatography, J. Cazes (Editor), Marcel Dekker, New York , 2001, Chap. 151.

82.)      David S. Hage* and Sanjay Mukherjee, "Binding Constants: Determination by Affinity Chromatography", In: Encyclopedia of Chromatography, J. Cazes (Editor), Marcel Dekker, New York , 2001, Chap. 27.

70.)      David S. Hage*, "Periodate Oxidation of Antibodies for Site-Selective Immobilization in  Immunoaffinity Chromatography", In: Affinity Chromatography: Methods and Protocols, P. Bailon, G. W. Ehrlich, W.-J. Fung and W. Berthold (Eds.), Humana Press, Totowa , NJ ; 2000, Chapter 7.

71.)      David S. Hage* and John Austin, "High-Performance Affinity Chromatography and Immobilized Serum Albumin as Probes for Drug- and Hormone-Protein Binding", J. Chromatogr. B, 739 (2000) 39-54.

72.)      David S. Hage*, "Affinity Chromatography", In: Encyclopedia of Analytical Chemistry: Instrumentation and Applications, R. A. Meyers (Editor-in-chief), Wiley, New York ; 2000.

73.)      Jennifer L. Brocky and David S. Hage*, "Separation of Near-Infrared Fluorescent Conjugates of dATP and Related Compounds by Capillary Electrophoresis", J. Chromatogr. B, 744 (2000) 315-321.

74.)      William Clarke, Julie D. Beckwith, Amiee Jackson, Bambi Reynolds, Elizabeth M. Karle and David S. Hage*, "Antibody Immobilization to High-Performance Liquid Chromatographic Supports: Characterization of Maximum Loading Capacity for Intact Immunoglobulin G and Fab Fragments", J. Chromatogr. A, 888 (2000) 13-22.

75.)      John Kenkel*, Paul B. Kelter and David S. Hage, Chemistry: An Industry-Based Introduction, CRC Press, Boca Raton , FL ; 2000.

28.)      John Rollag, Tsentao Liu and David S. Hage*, "Analysis of MHPG in Urine using Tandem Reversed-Phase Liquid Chromatography with Electrochemical Detection", J. Chromatogr. B, 663 (1995) 193-200.

29.)      K. Machele Miller and David S. Hage*, "Survey of Long Term Integrated Laboratory Use in Undergraduate Chemistry Programs", J. Chem. Educ., 72 (1995) 248-250.

30.)      David S. Hage*, Terence A. G. Noctor and Irving W. Wainer, "Characterization of the Protein Binding of Chiral Drugs by High-Performance Affinity Chromatography: Interactions of R- and S-Ibuprofen with Human Serum Albumin", J. Chromatogr. A, 693 (1995) 23-32.

31.)      Bounthon Loun and David S. Hage*, "Characterization of Thyroxine-Albumin Binding using High-Performance Affinity Chromatography. II. Comparison of the Binding of Thyroxine, Triiodothyronines and Related Compounds at the Warfarin and Indole Sites of Human Serum Albumin", J. Chromatogr. B, 665 (1995) 303-314.

32.)      David S. Hage*, "Immunoassays", Anal. Chem., 67 (1995) 455R-462R (Invited review).

33.)      Carrie A. C. Wolfe and David S. Hage*, "Studies on the Rate and Control of Antibody Oxidation by Periodate", Anal. Biochem., 231 (1995) 123-130.

34.)       David S. Hage*, "Gas Chromatography", In: Principles of Laboratory Methods, M. Haven (Ed.).  Van Nostrand Reinhold: New York ; 1995, Chap. 15 (Invited book chapter).

35.)       Bounthon Loun and David S. Hage*, "Chiral Separation Mechanisms in Protein-Based HPLC Columns. II. Kinetic Studies of R- and S-Warfarin Binding to Immobilized Human Serum Albumin", Anal. Chem., 68 (1996) 1218-1225.

36.)       Ju Yang, Sahana Roy Choudhuri and David S. Hage*, "Improved Reproducibility in Capillary Electrophoresis through the use of Mobility and Migration Time Ratios", J. Chromatogr. A, 725 (1996) 273-285.

37.)       Ju Yang and David S. Hage*, "Role of Binding Capacity versus Binding Strength in the Separation of Chiral Compounds by Protein-Based HPLC Columns", J. Chromatogr. A, 725 (1996) 273-285.

38.)       Wanda S. Reiter and David S. Hage*, "Optimization of HPLC Detection for Acridinium Ester-Labeled Antibodies", J. Clin. Ligand Assay, 19 (1996) 246-252.

39.)       Jasbir Singh, Tian C. Zhang*, Patrick J. Shea, Steven D. Comfort, Lakhwinder S. Hundal and David S. Hage, "Transformation of Atrazine and Nitrate in Contaminated Water by Iron Promoted Processes", Proceedings of WEFTEC'96, Vol. 3, Part 1: Remediation of Soil and Groundwater, Water Environment Federation, Alexandria, VA, 1996, pp. 143-150.

40.)       John G. Rollag, Melissa Beck-Westermeyer and David S. Hage*, "Analysis of Pesticide Degradation Products by Tandem High-Performance Immunoaffinity Chromatography and Reversed-Phase Liquid Chromatography", Anal. Chem., 68 (1996) 3631-3637.

41.)       John G. Rollag, Tsentao Liu and David S. Hage*, "Optimization of Post-Column Chemiluminescent Detection for Low-Molecular Mass Conjugates of Acridinium Esters", J. Chromatogr. A, 765 (1997) 145-155.

42.)       Anuja Chattopadhyay and David S. Hage*, "Determination of the Diol Content of Chromatographic Supports by Capillary Electrophoresis", J. Chromatogr. A, 758 (1997) 255-261.

43.)       Ju Yang and David S. Hage*, "Effect of Mobile Phase Composition on the Binding Kinetics of Chiral Solutes on a Protein-Based HPLC Column: Interactions of D- and L-tryptophan with Immobilized Human Serum Albumin", J. Chromatogr. A, 766 (1997) 15-25.

44.)       David S. Hage*, "Immunoassays", Anal. Chem., 69 (1997) 165R-171R, 214R-218R (Invited review).

45.)       David S. Hage*, John G. Rollag and David H. Thomas, "Analysis of Atrazine and its Degradation Products in Water by Tandem High-Performance Immunoaffinity Chromatography and Reversed-Phase Liquid Chromatography", In: Immunochemical Technology for Environmental Applications, D. S. Aga and E. M. Thurman (Eds.).  ACS Press, Washington , DC ; 1997, Chap. 10 (Invited book chapter).

46.)       Sahana Bose, Ju Yang and David S. Hage*, "Guidelines in Selecting Ligand Concentrations for the Determination of Binding Constants by Affinity Capillary Electrophoresis", J. Chromatogr. B, 697 (1997) 77-88.

47.)       David S. Hage*, "Chiral Separations in Capillary Electrophoresis using Proteins as Stereoselective Binding Agents", Electrophoresis, 18 (1997) 2311-2321.

48.)       David S. Hage* and Stacey A. Tweed, "Recent Advances in Chromatographic and Electrophoretic Methods for the Study of Drug-Protein Interactions", J. Chromatogr. B, 699 (1997) 499-528 (Invited review).

49.)       Paul B. Kelter*, Julie Grundman, David S. Hage and James D. Carr, "A Discussion of Water Pollution in the United States and Mexico with a Focus on High School Laboratory Activities for the Analysis of Lead, Atrazine and Nitrate, J. Chem. Educ., 74 (1997) 1413-1421.

50.)       David S. Hage*, "Principles and Practice of Immunoassay" (Book Review), Trends Biotechnol., 15 (1997) 480-481.

51.)       David S. Hage*, Carrie A. C. Wolfe and Matthew R. Oates, "Development of a Kinetic Model to Describe the Effective Rate of Antibody Oxidation by Periodate", Bioconj. Chem., 8 (1997) 914-920.

52.)       Stacey A. Tweed, Bounthon Loun and David S. Hage*, "Effects of Ligand Heterogeneity in the Characterization of Affinity Columns by Frontal Analysis", Anal. Chem., 69 (1997) 4790-4798.

53.)       David S. Hage*, "Chromatographic Approaches to Immunoassays", J. Clin. Ligand Assay, 20 (1997) 293-301 (Invited review).

54.)       John G. Rollag and David S. Hage*, "Non-Linear Elution Effects in Split-Peak Chromatography. 2. Role of Ligand Heterogeneity in Solute Binding to Columns with Adsorption-Limited Kinetics", J. Chromatogr. A, 795 (1998) 185-198.

55.)       Carrie A. C. Wolfe, Matthew R. Oates and David S. Hage*, "Automated Protein Assay using Flow Injection Analysis", J. Chem. Educ., 75 (1998) 1025-1028.

56.)       David S. Hage*, "Affinity Chromatography", In: Handbook of HPLC, E. Katz, R. Eksteen, P. Schoenmakers and N. Miller (Eds.).  Marcel Dekker, New York ; 1998, Chap. 13.

57.)       Matthew R. Oates, William C. Clarke and David S. Hage*, "Kinetic Studies on the Immobilization of Antibodies to High-Performance Liquid Chromatographic Supports", Bioconj. Chem., 9 (1998) 459-465.

58.)       David S. Hage*, "A Survey of Recent Advances in Analytical Applications of Immunoaffinity Chromatography", J. Chromatogr. B, 715 (1998) 3-28 (Invited review).

59.)       Anuja Chattopadhyay, Tong Tian, Laurie Kortum and David S. Hage*, "Development of Tryptophan-Modified Human Serum Albumin Columns for Site-Specific Studies of Drug-Protein Interactions by High-Performance Affinity Chromatography, J. Chromatogr. B, 715 (1998) 183-190.

60.)       David S. Hage* and Arundhati Sengupta, "Studies of Protein Binding to Non-Polar Solutes by using Zonal Elution and High-Performance Affinity Chromatography: Interactions of cis- and trans-Clomiphene with Human Serum Albumin in the Presence of $-Cyclodextrin", Anal. Chem., 70 (1998) 4602-4609.

61.)       Jasbir Singh, Patrick J. Shea*, Lakhwinder S. Hundal, Steve D. Comfort, Tian C. Zhang and David S. Hage, "Iron-Enhanced Remediation of Water and Soil Containing Atrazine", Weed Science, 49 (1998) 381-390.

62.)       David S. Hage*, Anuja Chattopadhyay, Carrie A. C. Wolfe, Julie Grundman and Paul B. Kelter, "Determination of Nitrate and Nitrite in Water by Capillary Electrophoresis", J. Chem. Educ., 75 (1998) 1588-1590.

63.)      Jeffrey M. Ashley, Bruce I. Dvorak*, David S. Hage and Matthew Oates, "Activated Carbon Treatment of s-Triazines and Their Metabolites", Proc. ASCE Environ. Eng. Conf.; Amer. Soc. Civil Engin. , Washington DC; 1998, pp. 338-343.

64.)      Arundhati Sengupta and David S. Hage*, "Characterization of the Binding of Digitoxin and Acetyldigitoxin to Human Serum Albumin by High-Performance Affinity Chromatography", J. Chromatogr. B., 725 (1999) 91-100.

65.)      David S. Hage*, "Immunoassays", Anal. Chem., 71 (1999) 294R-304R.

66.)      David S. Hage*, David H. Thomas, A. Roy Chowdhuri and William Clarke, "Development of a Theoretical Model for Chromatographic-Based Competitive Binding Immunoassays with Simultaneous Injection of Sample and Label", Anal. Chem., 71 (1999) 2965-2975.

67.)      David S. Hage*, "Affinity Chromatography: A Review of Clinical Applicatiions", Clin. Chem., 45 (1999) 593-615.

68.)      Jeffrey M. Ashley, Bruce I. Dvorak* and David S. Hage, "GAC and PAC Systems Analysis: Implications of the Regulation of s-Triazine Metabolites", Amer. Water Works Assoc. Ann. Conf., Amer. Water Works Assoc., Washington DC; 1999, p. W-16-5.

69.)      Arundhati Sengupta and David S. Hage*, "Characterization of Minor Site Probes for Human Serum Albumin by High-Performance Affinity Chromatography", Anal. Chem., 71 (1999) 3821-3827.

1984-1994

1.)        David S. Hage* and Rodney R. Walters, “Non-linear elution effects in split-peak chromatography.  I. Computer simulations for the cases of irreversible diffusion- and adsorption-limited kinetics”, J. Chromatogr., 436(2) (1988) 111-35.

2.)        David S. Hage*, “Split-peak determination of protein adsorption kinetics in high-performance affinity chromatography”’ Diss. Abstr. Int. B 48(4) (1987) 1025-6.

3.)        David S. Hage* and Rodney R. Walters, “Dual-column determination of albumin and immunoglobulin G in serum by high-performance affinity chromatography” ,  J. Chromatogr., 386 (1987) 37-49.

4.)        David S. Hage*, Rodney R. Walters and Herbert W. Hethcote, “Split-peak affinity chromatographic studies of the immobilization-dependent adsorption kinetics of protein A, Anal. Chem. 58(2) (1986) 274-9.

5.)        David S. Hage* and Paul J. Taylor, “Spectroscopy interfacing package.  Part 1:  Spectrum recorder”, Computer Applications in the Lab.  2(2) (1984) 100-8.

6.)        David S. Hage* and Paul J. Taylor, “Spectroscopy interfacing package. Part II: Spectrum Worker”, Computer Applications in the Lab.  2(4) (1984) 226-33.

7.)        David S. Hage* and Paul J. Taylor, “Spectroscopy interfacing package.  Part 3:  spectrum plotter”,  Computer Applications in the Lab.  2(5) (1984)  326-31.

8.)        David S. Hage*, Bob Taylor, Pat Schryver and Pai C. Kao, "Use of Affinity Chromatography in Developing Acridinium Ester-labeled Antibodies for an Immunometric Assay of Parathyrin", Clin. Chem., 37 (1991) 117-118.

9.)        David S. Hage* and Pai C. Kao, "High-Performance Immunoaffinity Chromatography and Chemiluminescence in the Automation of a Parathyroid Hormone Sandwich Immunoassay", Anal. Chem., 63 (1991) 586-595.

10.)      David S. Hage*, "Immunoassays", Anal. Chem., 63 (1991) 206R-209R (Invited review).

11.)      David S. Hage*, Robert L. Taylor and Pai C. Kao, "Improved Recovery of a Radiolabeled Peptide with an Albumin-treated Reversed-phase HPLC Column", Clin. Chem., 38 (1992) 303-304.

12.)      David S. Hage*, Bob Taylor and Pai C. Kao, "Intact Parathyroid Hormone:  Performance and Clinical Utility of an Automated Assay Based on High-Performance Immunoaffinity Chromatography and Chemiluminescent Detection", Clin. Chem., 38 (1992) 1494-1500.

13.)      Terence A. G. Noctor*, Irving W. Wainer and David S. Hage, "Allosteric and Competitive Displacement of Drugs from Human Serum Albumin by Octanoic Acid, as Revealed by High-Performance Liquid Affinity Chromatography on a Human Serum Albumin-Based Stationary Phase", J. Chromatogr., 579 (1992) 305-315.

14.)      Bounthon Loun and David S. Hage*, "Characterization of Thyroxine-Albumin Binding using High-Performance Affinity Chromatography", J. Chromatogr., 579 (1992) 225-235.

15.)      David S. Hage*, David H. Thomas and Melissa S. Beck, "Theory of a Sequential Addition Competitive Binding Immunoassay Based on High-Performance Immunoaffinity Chromatography", Anal. Chem., 65 (1993) 1622-1630.

16.)      Ju Yang and David S. Hage*, "Characterization of the Binding and Chiral Separation of D- and L-Tryptophan on a High-Performance Immobilized Human Serum Albumin Column", J. Chromatogr., 645 (1993) 241-250.

17.)      David S. Hage*, "Immunoassays", Anal. Chem., 65 (1993) 420R-424R (Invited review).

18.)      David S. Hage*, "Chromatography", In: Principles of Laboratory Instruments, L. Schoeff and R. H. Williams (Eds.).  Mosby: St. Louis , MO ; 1993 (Invited book chapter).

19.)      David S. Hage*, "Chemiluminescent Detection in High-Performance Liquid Chromatography", In: HPLC Detection - Newer Methods, G. Patonay (Ed.).  VCH: New York ; 1993 (Invited book chapter).

20.)      Peggy F. Ruhn, Susan Garver and David S. Hage*, "Development of Dihydrazide-Activated Silica Supports for High-Performance Affinity Chromatography", J. Chromatogr. A, 669 (1994) 9-19.

21.)      Charles Keener, Carrie A. C. Wolfe and David S. Hage*, "Optimization of Oxidized Antibody Labeling with Lucifer Yellow CH", Biotechniques, 16 (1994) 894-897.

22.)      Carrie A. C. Wolfe and David S. Hage*, "Automated Determination of Antibody Oxidation using Flow Injection Analysis", Anal. Biochem., 219 (1994) 26-31.

23.)      Ju Yang, X.-Z. Wang, David S. Hage*, Patricia L. Herman, and Donald P. Weeks, "Analysis of Dicamba Degradation by Pseudomonas maltophilia using High-Performance Capillary Electrophoresis", Anal. Biochem., 219 (1994) 37-42.

24.)      Ju Yang and David S. Hage*, "Chiral Separations in Capillary Electrophoresis using Human Serum Albumin as a Buffer Additive", Anal. Chem., 66 (1994) 2719-2725.

25.)      David H. Thomas, Melissa Beck-Westermeyer and David S. Hage*, "Determination of Atrazine in Water using High-Performance Immunoaffinity Chromatography and Reversed-Phase Liquid Chromatography", Anal. Chem., 66 (1994) 3823-3829.

26.)      Bounthon Loun and David S. Hage*, "Chiral Separation Mechanisms in Protein-Based HPLC Columns. I. Thermodynamic Studies of R- and S-Warfarin Binding to Immobilized Human Serum Albumin", Anal. Chem., 66 (1994) 3814-3822.

27.)      Peggy F. Ruhn, J. D. Taylor and David S. Hage*, "Determination of Urinary Albumin using High-Performance Immunoaffinity Chromatography and Flow Injection Analysis", Anal. Chem., 66 (1994) 4265-4271.